GlassScriptPhysician profile
Kevin C Phillips
NPI 1881616258
$1,355.49
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.64 · 2020: $212 · 2021: $620 · 2022: $186 · 2023: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $494.80 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $273.26 | 2021-2023 | Verquvo, Belsomra, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.91 | 2021-2023 | Spiriva Respimat, Jardiance, Stiolto Respimat |
| Janssen Pharmaceuticals, INC | $95.85 | 2021-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $80.27 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $64.43 | 2020-2022 | |
| Amarin Pharma, INC. | $41.97 | 2021 | |
| Boston Scientific Corporation | $33.29 | 2022 | |
| Pfizer INC. | $32.51 | 2020-2022 | |
| Astellas Pharma US INC | $25.39 | 2019-2020 | |
| Myovant Sciences INC. | $20.86 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $18.93 | 2023 | Inpefa |
| Amgen INC. | $17.37 | 2019 | |
| Medtronic, INC. | $14.49 | 2023 | Micra |
| Therapeuticsmd, INC. | $14.39 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $14.29 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.